domingo, 16 de agosto de 2026

Link Drug And Diagnostic Policy Pathways To Reach Patients Most Likely To Benefit Kathryn A. Phillips August 11, 2026

https://www.healthaffairs.org/content/forefront/link-drug-and-diagnostic-policy-pathways-reach-patients-most-likely-benefit?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_sFmTtMrndymOyN7LeUqPz0v-Jju2YSijgJrOcKvmlqPqfT-TZBBpxI6-tu_5VTJT41_aOfclTjj6REviw2ssfe3VMHA&_hsmi=433307009&utm_source=hasu We must move away from evaluating tests and drugs as separate technologies when they are clinically tied together. We should be assessing them instead as interconnected care, requiring interconnected policy pathways.

No hay comentarios:

Publicar un comentario